Tower Research Capital (TRC)’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,179
| Closed | -$61.3K | – | 5290 |
|
|
2025
Q1 | $61.3K | Buy |
15,179
+4,563
| +43% | +$15.2K | ﹤0.01% | 2086 |
|
|
2024
Q4 | $34K | Buy |
10,616
+6,486
| +157% | +$22K | ﹤0.01% | 2814 |
|
|
2024
Q3 | $9.25K | Sell |
4,130
-9,123
| -69% | -$21.1K | ﹤0.01% | 3886 |
|
|
2024
Q2 | $28.5K | Buy |
13,253
+6,027
| +83% | +$10.7K | ﹤0.01% | 3523 |
|
|
2024
Q1 | $14.8K | Sell |
7,226
-3,948
| -35% | -$7.88K | ﹤0.01% | 3282 |
|
|
2023
Q4 | $25.6K | Buy |
11,174
+5,375
| +93% | +$11.7K | ﹤0.01% | 3505 |
|
|
2023
Q3 | $9.86K | Buy |
+5,799
| New | +$13.2K | ﹤0.01% | 4172 |
|
|
2023
Q2 | – | Sell |
-14,961
| Closed | -$34K | – | 6067 |
|
|
2023
Q1 | $34K | Buy |
14,961
+5,413
| +57% | +$27.2K | ﹤0.01% | 2855 |
|
|
2022
Q4 | $49K | Buy |
9,548
+9,104
| +2,050% | +$65.6K | ﹤0.01% | 2363 |
|
|
2022
Q3 | $5K | Sell |
444
-207
| -32% | -$2.47K | ﹤0.01% | 5128 |
|
|
2022
Q2 | $7K | Buy |
651
+365
| +128% | +$4.78K | ﹤0.01% | 4769 |
|
|
2022
Q1 | $5K | Buy |
+286
| New | +$6.14K | ﹤0.01% | 5029 |
|
|
2021
Q4 | – | Sell |
-175
| Closed | -$6K | – | 6169 |
|
|
2021
Q3 | $6K | Buy |
+175
| New | +$5.17K | ﹤0.01% | 4733 |
|
|
2021
Q2 | – | Sell |
-1,404
| Closed | -$44K | – | 5506 |
|
|
2021
Q1 | $44K | Buy |
1,404
+596
| +74% | +$20K | ﹤0.01% | 3233 |
|
|
2020
Q4 | $21K | Sell |
808
-3,831
| -83% | -$96.9K | ﹤0.01% | 3833 |
|
|
2020
Q3 | $124K | Buy |
4,639
+3,840
| +481% | +$92.2K | ﹤0.01% | 2970 |
|
|
2020
Q2 | $16K | Buy |
+799
| New | +$14.6K | ﹤0.01% | 3784 |
|
|
2019
Q4 | – | Sell |
-244
| Closed | -$6K | – | 3624 |
|
|
2019
Q3 | $6K | Sell |
244
-139
| -36% | -$3.81K | ﹤0.01% | 3205 |
|
|
2019
Q2 | $11K | Sell |
383
-190
| -33% | -$7.46K | ﹤0.01% | 2488 |
|
|
2019
Q1 | $16K | Sell |
573
-1,148
| -67% | -$36.6K | ﹤0.01% | 2390 |
|
|
2018
Q4 | $31K | Buy |
+1,721
| New | +$41K | ﹤0.01% | 1601 |
|
|
2018
Q3 | – | Sell |
-64
| Closed | -$2K | – | 3807 |
|
|
2018
Q2 | $2K | Buy |
+64
| New | +$2.21K | ﹤0.01% | 3308 |
|
Tower Research Capital (TRC)'s CKPT Position: Q2 2025 in Review
Tower Research Capital (TRC) sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 15,179 shares — an estimated $61.3K sold.
Tower Research Capital (TRC) first reported a position in CKPT in Q2 2018 and held it in 22 quarters. The position peaked at $124K in Q3 2020. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.
- Tower Research Capital (TRC) reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 15,179 Checkpoint Therapeutics shares in Q2 2025, an estimated $61.3K.
- Tower Research Capital (TRC) first reported a position in Checkpoint Therapeutics in Q2 2018 and held it in 22 quarters.
- Tower Research Capital (TRC)'s Checkpoint Therapeutics position peaked at $124K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.